CD4 and neoplasm: In this study, we found that a high frequency of CD4+FoxP3+Helios+ Tregs in blood was associated with shorter DFS, suggesting the potential role of this highly immunosuppressive Treg subset in inhibiting anti-tumor immune responses, and consequently worsening clinical outcomes.